Abigail Drew Pothen
Nurse Practitioner · West Columbia
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 7 years
- Graduated 2019
Offices
1 location · Southern Urogynecology LLC · 5 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Abigail Drew Pothen’s office at (803) 457-7000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$21,415
Medicare paid this office $21,415 for 162 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 83 | $5,748 | $52 |
| Return visit (30+ min) | 49 | $4,136 | $77 |
| New patient visit (45+ min) | 31 | $2,889 | $93 |
| New patient visit (30+ min) | 40 | $2,467 | $62 |
| Simple bladder irrigation and/or instillation | 13 | $997 | $43 |
See all 8 services
| Short return visit (20+ min) | 83 | $5,748 | $52 |
| Return visit (30+ min) | 49 | $4,136 | $77 |
| New patient visit (45+ min) | 31 | $2,889 | $93 |
| New patient visit (30+ min) | 40 | $2,467 | $62 |
| Simple bladder irrigation and/or instillation | 13 | $997 | $43 |
| Ultrasound measurement of bladder capacity after voiding | 119 | $962 | $7 |
| Short return visit | 12 | $428 | $33 |
| Automated urinalysis test | 124 | $379 | $2 |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | 22 | 44 | 34 | 44 | 138 |
| Fitting and insertion of vaginal support device | 16 | 48 | 42 | 27 | – |
| Simple bladder irrigation and/or instillation | – | – | – | – | 23 |
| Insertion of temporary bladder tube | – | 11 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
162 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 19% · Also on Medicaid 17% · Health risk score 1.54. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 45% · Chronic kidney disease 42% · Depression 38% · Coronary heart disease 36% · Heart failure 27% · Atrial fibrillation 20% · COPD 19% · Cancer 17% · Stroke 14% · Dementia 13%.
The office billed $78,852, Medicare allowed $28,974 and paid $21,415; for 776 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 162 | 776 | 75 | 1.54 | $78,852 | $21,415 |
| 2023 | 138 | 338 | 75 | 0.94 | $78,296 | $13,491 |
| 2022 | 204 | 563 | 74 | 0.84 | $154,055 | $25,394 |
| 2021 | 203 | 484 | 74 | 0.98 | $133,017 | $24,317 |
| 2020 | 83 | 197 | 74 | 1.04 | $33,829 | $8,811 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 51 | $3,784 | $68 |
| Short return visit (20+ min) | 42 | $2,304 | $54 |
| New patient visit (45+ min) | 19 | $1,703 | $90 |
| Pessary, reusable, non rubber, any type | 24 | $1,169 | $43 |
| Fitting and insertion of vaginal support device | 24 | $1,145 | $42 |
| Short return visit | 24 | $742 | $26 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $429 | $33 |
| Ultrasound measurement of bladder capacity after voiding | 37 | $323 | $7 |
| Automated urinalysis test | 38 | $95 | $2 |
2022: 9 services
| Return visit (30+ min) | 83 | $8,722 | $84 |
| Short return visit (20+ min) | 61 | $3,995 | $52 |
| New patient visit (45+ min) | 37 | $3,852 | $104 |
| Fitting and insertion of vaginal support device | 36 | $1,830 | $44 |
| Short return visit | 34 | $1,736 | $37 |
| Pessary, reusable, non rubber, any type | 32 | $1,638 | $43 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 26 | $872 | $34 |
| Ultrasound measurement of bladder capacity after voiding | 32 | $253 | $7 |
| Automated urinalysis test | 56 | $134 | $2 |
2021: 11 services
| Return visit (30+ min) | 65 | $6,598 | $79 |
| New patient visit (45+ min) | 52 | $5,122 | $99 |
| Short return visit (20+ min) | 51 | $3,504 | $59 |
| Fitting and insertion of vaginal support device | 37 | $2,248 | $47 |
| Short return visit | 35 | $1,464 | $34 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,042 | $34 |
| Pessary, reusable, rubber, any type | 35 | $825 | $19 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 20 | $744 | $37 |
| Ultrasound measurement of bladder capacity after voiding | 40 | $350 | $8 |
| Insertion of temporary bladder tube | 11 | $348 | $32 |
| Automated urinalysis test | 12 | $27 | $2 |
2020: 6 services
| New patient visit (45+ min) | 32 | $3,632 | $114 |
| Short return visit (20+ min) | 24 | $1,345 | $52 |
| Fitting and insertion of vaginal support device | 13 | $745 | $47 |
| Pessary, reusable, rubber, any type | 11 | $249 | $19 |
| Ultrasound measurement of bladder capacity after voiding | 20 | $184 | $8 |
| Automated urinalysis test | 37 | $92 | $2 |
Medicaid work
$1,526 in 2024
Medicaid paid $1,526 for 193 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 36 | $1,135 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 61 | $271 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 96 | $121 |
| 2024 | 193 | 3 | 19 | $1,526 |
| 2023 | 44 | 3 | 16 | $1,223 |
| 2022 | 12 | 1 | 12 | $794 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 14 | $1,147 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 12 | $59 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 18 | $17 |
2022
| Return visit (30+ min) | 12 | $794 |
Drugs they prescribed that Part D paid
$144,776
Pharmacies billed $144,776 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 566) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
364 generic and 202 brand-name prescriptions · $144,776 in drug cost · 70 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 80 | $62,228 | $778 |
| Myrbetriq | 98 | $54,101 | $552 |
| Estradiol | 127 | $7,951 | $63 |
| Estring | 14 | $7,368 | $526 |
| Mirabegron Er | 11 | $5,152 | $468 |
See all 13 drugs
| Gemtesa | 80 | $62,228 | $778 |
| Myrbetriq | 98 | $54,101 | $552 |
| Estradiol | 127 | $7,951 | $63 |
| Estring | 14 | $7,368 | $526 |
| Mirabegron Er | 11 | $5,152 | $468 |
| Solifenacin | 19 | $1,557 | $82 |
| Clobetasol Propionate | 13 | $429 | $33 |
| Nitrofurantoin Mono-Macro | 21 | $382 | $18 |
| Clotrimazole-Betamethasone | 15 | $127 | $8 |
| Cephalexin | 17 | $75 | $4 |
| Fluconazole | 13 | $72 | $6 |
| Tamsulosin | 17 | $70 | $4 |
| Ciprofloxacin | 15 | $52 | $3 |
Year by year
| 2024 | 566 | 171 | 0% (0) | 36% | $144,776 |
| 2023 | 315 | 122 | 0% (0) | 31% | $75,479 |
| 2022 | 379 | 157 | 0% (0) | 20% | $64,387 |
| 2021 | 324 | 141 | 0% (0) | 15% | $37,617 |
| 2020 | 101 | 56 | 0% (0) | 14% | $8,934 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Myrbetriq | 42 | $28,654 | $682 |
| Gemtesa | 29 | $19,777 | $682 |
| Estradiol | 113 | $8,439 | $75 |
| Progesterone | 19 | $934 | $49 |
| Clobetasol Propionate | 16 | $406 | $25 |
| Nitrofurantoin Mono-Macro | 13 | $187 | $14 |
2022: 9 drugs
| Myrbetriq | 46 | $36,911 | $802 |
| Estradiol | 114 | $11,413 | $100 |
| Clobetasol Propionate | 22 | $1,082 | $49 |
| Cyclobenzaprine | 14 | $631 | $45 |
| Gabapentin | 16 | $474 | $30 |
| Valacyclovir | 12 | $328 | $27 |
| Nitrofurantoin Mono-Macro | 17 | $288 | $17 |
| Fluconazole | 19 | $149 | $8 |
| Cephalexin | 13 | $77 | $6 |
2021: 6 drugs
| Estradiol | 132 | $15,850 | $120 |
| Myrbetriq | 16 | $9,690 | $606 |
| Nitrofurantoin Mono-Macro | 25 | $702 | $28 |
| Clobetasol Propionate | 24 | $584 | $24 |
| Cyclobenzaprine | 12 | $231 | $19 |
| Fluconazole | 16 | $203 | $13 |
2020: 3 drugs
| Estradiol | 26 | $3,389 | $130 |
| Nitrofurantoin Mono-Macro | 15 | $309 | $21 |
| Fluconazole | 13 | $104 | $8 |
Money from drug and device companies
$515 in 2025
| 2025 | 4 | 18 | None | $515 |
| 2024 | 9 | 31 | None | $1,882 |
| 2023 | 6 | 11 | None | $448 |
| 2022 | 6 | 10 | None | $343 |
| 2021 | 3 | 10 | None | $222 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Interstim | $199 | 5 payments
|
| Sumitomo Pharma America | Gemtesa | $170 | 6 payments
|
| Abbvie | Botox | $120 | 6 payments
|
| Ambu | None | $26 | 1 payment
|
See all 18 published payments
| Abbvie | Meals · 2025-12-15 | Botox | $18 |
| Sumitomo Pharma America | Meals · 2025-12-02 | Gemtesa | $29 |
| Abbvie | Meals · 2025-11-17 | Botox | $18 |
| Medtronic | Meals · 2025-11-07 | Interstim | $14 |
| Abbvie | Meals · 2025-10-29 | Botox | $19 |
| Sumitomo Pharma America | Meals · 2025-10-21 | Gemtesa | $26 |
| Abbvie | Meals · 2025-09-25 | Botox | $21 |
| Sumitomo Pharma America | Meals · 2025-09-23 | Gemtesa | $30 |
| Abbvie | Meals · 2025-09-22 | Lo Loestrin Fe | $16 |
| Medtronic | Meals · 2025-09-03 | Interstim | $48 |
| Sumitomo Pharma America | Meals · 2025-08-27 | Gemtesa | $29 |
| Abbvie | Meals · 2025-08-26 | Botox | $27 |
| Medtronic | Meals · 2025-08-13 | Interstim | $91 |
| Sumitomo Pharma America | Meals · 2025-07-16 | Gemtesa | $30 |
| Sumitomo Pharma America | Meals · 2025-06-25 | Gemtesa | $27 |
| Medtronic | Meals · 2025-05-20 | Interstim | $25 |
| Ambu | Meals · 2025-01-09 | None | $26 |
| Medtronic | Meals · 2025-01-08 | Interstim | $21 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,882
| Medtronic | Interstim | $1,564 | 18 payments
|
| Sumitomo Pharma America | Gemtesa | $104 | 4 payments
|
| Abbvie | Botox | $61 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $48 | 2 payments
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $27 | 1 payment
|
| Coloplast | Luja Coude | $23 | 1 payment
|
| 180 Medical | Gentlecath | $20 | 1 payment
|
| Axonics | Axonics | $19 | 1 payment
|
| Ambu | None | $17 | 1 payment
|
2023: $448
| Medtronic | Interstim | $246 | 5 payments
|
| Astellas Pharma US | Myrbetriq | $118 | 2 payments
|
| Tolmar | Eligard | $29 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $20 | 1 payment
|
| Evofem Biosciences | Phexxi | $19 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $17 | 1 payment
|
2022: $343
| Astellas Pharma US | None | $183 | 2 payments
|
| Abbvie | Orilissa | $69 | 3 payments
|
| Pfizer | Premarin | $44 | 2 payments
|
| Endo Pharmaceuticals | Xiaflex | $21 | 1 payment
|
| Kowa Pharmaceuticals America | Seglentis | $14 | 1 payment
|
| Olympus America | Itind System | $12 | 1 payment
|
2021: $222
| AbbVie | Orilissa | $103 | 5 payments
|
| Astellas Pharma US | Xtandi | $82 | 4 payments
|
| Medtronic | Interstim | $37 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 99.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780217513
- Licence
- GA RN231880, SC 27410
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LW0102X (363LW0102X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2020-02-20
- NPI last updated
- 2026-05-11
- NPI record certified
- 2026-05-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1800 Peachtree St Nw Ste 700, Atlanta, GA, 30309 · 11660 Alpharetta Hwy Ste 710, Roswell, GA, 30076